FDA's new guidelines say amyloid reduction is good enough for approval, used as a substitute for actual benefit. That's because amyloid reduction doesn't provide any benefit, but in all the drugs thus far has caused brain bleeds. So if Big Pharma is still to be able to suck up taxpayer dollars for useless drugs, we must allow a useless marker to substitute for actual benefit.

Not that I'm disgusted or anything.